What is the likely diagnosis for petechial skin lesions that flare up with sun exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Petechial Skin Lesions Flaring with Sun Exposure

The most likely diagnosis is solar capillaritis (also called solar purpura), a rare photodermatosis characterized by asymptomatic petechial eruptions that develop acutely after sun exposure, typically on the lower extremities 1.

Differential Diagnosis Framework

When evaluating petechial lesions that flare with outdoor/sun exposure, consider these key diagnostic possibilities:

Primary Consideration: Solar Capillaritis

  • Clinical presentation: Asymptomatic petechial eruptions appearing acutely after strong sun exposure, most commonly on the legs 1
  • Pathophysiology: Capillaritis triggered by ultraviolet A (UVA) wavelengths 1
  • Histology: Shows features of capillaritis on biopsy of evoked lesions 1
  • Key distinguishing feature: The eruption manifests as confluent petechiae strictly limited to sun-exposed areas, differing from classical sunburn 2

Drug-Induced Solar Capillaritis

Critical caveat: Always obtain a complete medication history, as certain drugs can trigger photolocalized purpura:

  • Fluoroquinolones (particularly levofloxacin): Can cause pruritic purpuric eruptions on sun-exposed lower extremities, presenting as confluent petechiae with pruritus 2
  • Other photosensitizing medications: ACE inhibitors, angiotensin receptor blockers, amiodarone, and thiazide diuretics can cause various photosensitive eruptions 3

Alternative Photodermatoses to Consider

Polymorphic Light Eruption (PLE):

  • More common (10-20% prevalence) 4
  • Typically presents as erythematous papules, vesicles, or plaques—not petechiae 5, 4
  • Develops 30 minutes to 1-3 days after sun exposure 5
  • Usually affects arms, forearms, hands, head/neck with facial sparing 5
  • Key difference: PLE rarely presents as petechiae; when it does occur in darker skin types (phototype IV-VI), it manifests as pinpoint papules (1-2mm), not purpura 5

Porphyrias (if blistering/fragility present):

  • Cutaneous porphyrias cause skin damage from photoactivation of porphyrins at 400-410nm wavelengths 6
  • Present with bullae, skin fragility, and scarring—not isolated petechiae 6
  • Would show increased plasma porphyrins on fluorescence scanning 6

Diagnostic Approach

Essential Workup

  1. Detailed exposure history: Document temporal relationship between sun exposure and lesion onset
  2. Complete medication review: Specifically ask about fluoroquinolones, antihypertensives, diuretics, and antiarrhythmics
  3. Phototesting: Determine action spectrum in specialized phototesting unit to identify triggering wavelengths 1
  4. Skin biopsy: Of an evoked lesion to confirm capillaritis histologically 1

What to Look For on Examination

  • Distribution: Strictly sun-exposed areas (legs most common, but can affect arms, face, neck)
  • Morphology: Confluent petechiae without palpable purpura
  • Associated symptoms: Usually asymptomatic, though drug-induced cases may have pruritus 2
  • Absence of: Blistering, scarring, or skin fragility (which would suggest porphyria)

Management Strategy

Immediate actions:

  • Discontinue any photosensitizing medications if drug-induced etiology suspected 2
  • Strict photoprotection: Seek shade during peak hours (10am-4pm), wear protective clothing, broad-brimmed hats, and broad-spectrum sunscreen (SPF ≥30) 3
  • Avoid reflection: Be particularly cautious around water, sand, and snow which intensify UV exposure 3

Treatment considerations:

  • Solar capillaritis is generally self-limited and resolves without intervention 1
  • Unlike PLE, there is no established role for prophylactic phototherapy or immunosuppression
  • Focus on prevention through photoprotection rather than active treatment

Critical Pitfalls to Avoid

  1. Don't assume all sun-induced eruptions are PLE: Solar capillaritis is distinct and requires different management
  2. Don't overlook medication triggers: Always review drugs before attributing to idiopathic photodermatosis
  3. Don't confuse with vasculitis: True vasculitis would show palpable purpura and systemic symptoms
  4. Don't miss porphyria: If any blistering, scarring, or skin fragility present, obtain plasma porphyrin fluorescence scanning 6

The evidence base for solar capillaritis is limited to case reports 1, 2, reflecting its rarity. However, recognition is important to avoid unnecessary investigations and provide appropriate counseling about photoprotection and medication review.

References

Research

Solar capillaritis as a cause of solar purpura.

Clinical and experimental dermatology, 2009

Research

Photolocalized purpura during levofloxacin therapy.

Photodermatology, photoimmunology & photomedicine, 2012

Research

Photodermatoses: diagnosis and treatment.

Deutsches Arzteblatt international, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.